<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02078232</url>
  </required_header>
  <id_info>
    <org_study_id>SFED NÂ°98</org_study_id>
    <nct_id>NCT02078232</nct_id>
  </id_info>
  <brief_title>Comparison of Two Needles (19G Flex Versus 22G Standard) for Pancreatic Solid Tumors Diagnosis</brief_title>
  <acronym>EASYFLEX</acronym>
  <official_title>Randomized, Comparative Study of 19G Flex Versus 22G Standard Needles for Pancreatic Solid Tumors Diagnosis.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>French Society of Digestive Endoscopy</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>French Society of Digestive Endoscopy</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare the diagnostic gain between 22G standard needle vs
      19G Flex needles transduodenal punctures of masses of the pancreatic head.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The negative predictive value of fine needle aspiration under ultrasound endoscopy (EUS-FNA)
      for the diagnosis of solid pancreatic masses is about 70 - 80 % with the 22G standard needle.
      Pancreatic adenocarcinoma is known to have a severe prognosis and a low rate of survival even
      after curative surgery. The study of pancreatic solid tumors is one the main diagnostic
      problem present in the investigators daily practice. In most of non operated patients,
      EUS-FNA is the sole possibility to confirm the diagnosis of malignancy which is required to
      initiate chemotherapy and/or radiotherapy. To improve the performances of the EUS-FNA, new
      needles are now disposable either with a cutting window design (EchoTip ProCore-COOK Medical)
      or flexible 19G needle (19G Expect Flex - Boston-Scientific). The goal is to obtain more
      tissue material with the possibility of a histologic study without increasing the risk of the
      puncture which is very low (complications rate &lt; 1%). The problem concerns the lesion of the
      head of the pancreas requiring a trans-duodenal access for the puncture . In this position,
      the needle is very difficult to push out the operator channel and, in some cases, the
      puncture is quite impossible with stiff needles as &quot;ProCore&quot; or standard 19G. Thus, the
      interest of flexible 19G needle is to be used in difficult technical cases as transduodenal
      access for head pancreatic tumors, with a good safety and more efficacy than 22G needles.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2013</start_date>
  <completion_date type="Actual">January 23, 2017</completion_date>
  <primary_completion_date type="Actual">July 6, 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>accuracy of 19G Flex Expect needle in the histological diagnosis of pancreatic solid tumors of the head of pancreas</measure>
    <time_frame>10 days</time_frame>
    <description>accuracy and diagnostic gain of fine needle aspiration under ultrasound endoscopy (EUS-FNA) for the diagnosis of solid pancreatic tumors of the head of pancreas: comparison between 19G Flex and 22G standard needles punctures.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>morbidity</measure>
    <time_frame>2 minutes, up to day 30</time_frame>
    <description>immediate per-procedure complications and delayed morbidity (up to day 30) side effects resulting of technical failure or dysfunction of the puncture ease of handling for the two needles (visual analogic scale)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>quality of histology</measure>
    <time_frame>10 days</time_frame>
    <description>quality of histological specimens obtained with the 2 types of needles (visual analogic scale)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">124</enrollment>
  <condition>Adenocarcinoma of Head of Pancreas</condition>
  <arm_group>
    <arm_group_label>19G flex needle puncture</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>puncture of head of pancreas</description>
  </arm_group>
  <arm_group>
    <arm_group_label>22G needle puncture</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>puncture of head of pancreas</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>puncture of head of pancreas</intervention_name>
    <description>puncture of head of pancreatic solid mass with fine needle aspiration under endoscopic ultrasonographic control.
randomization: puncture with either 22G needle or 19G flex needle</description>
    <arm_group_label>19G flex needle puncture</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>puncture of head of pancreas</intervention_name>
    <description>puncture of head of pancreatic solid mass with fine needle aspiration under endoscopic ultrasonographic control.
randomization: puncture with either 22G needle or 19G flex needle</description>
    <arm_group_label>22G needle puncture</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patient with solid tumor of pancreas who has to receive a biopsy under endoscopic
             ultrasound (EUS)

          -  patient who understands the study procedures, risks and voluntarily agrees to
             participate by giving written informed consent

        Exclusion Criteria:

          -  patient who participates in an other study

          -  patient mentally or legally incapacitated

          -  patient with contraindications to the achievement of upper gastrointestinal endoscopy

          -  patient with haemorrhagic disease, disorder of hemostasis and coagulation (TP&lt;60%,
             TCA&gt;40sec and platelets &lt;60000/mm3)

          -  patient with anticoagulant or antiaggregating treatment that could not be stopped for
             the endoscopic procedure

          -  patient with pancreatic cystic mass (fluid quota valued at more than 50% of the mass
             lesion on imaging)

          -  patient pregnant or lactating women
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>CHRISTIAN BOUSTIERE, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>FRENCH SDE</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hopital Saint Joseph</name>
      <address>
        <city>Marseille</city>
        <zip>13008</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <reference>
    <citation>Jenssen C, Dietrich CF. Endoscopic ultrasound-guided fine-needle aspiration biopsy and trucut biopsy in gastroenterology - An overview. Best Pract Res Clin Gastroenterol. 2009;23(5):743-59. doi: 10.1016/j.bpg.2009.05.006. Review.</citation>
    <PMID>19744637</PMID>
  </reference>
  <reference>
    <citation>Takemoto T, Aibe T, Fuji T, Okita K. Endoscopic ultrasonography. Clin Gastroenterol. 1986 Apr;15(2):305-19.</citation>
    <PMID>3524913</PMID>
  </reference>
  <reference>
    <citation>Erickson RA. EUS-guided FNA. Gastrointest Endosc. 2004 Aug;60(2):267-79. Review.</citation>
    <PMID>15278063</PMID>
  </reference>
  <reference>
    <citation>Hewitt MJ, McPhail MJ, Possamai L, Dhar A, Vlavianos P, Monahan KJ. EUS-guided FNA for diagnosis of solid pancreatic neoplasms: a meta-analysis. Gastrointest Endosc. 2012 Feb;75(2):319-31. doi: 10.1016/j.gie.2011.08.049.</citation>
    <PMID>22248600</PMID>
  </reference>
  <reference>
    <citation>Song TJ, Kim JH, Lee SS, Eum JB, Moon SH, Park DY, Seo DW, Lee SK, Jang SJ, Yun SC, Kim MH. The prospective randomized, controlled trial of endoscopic ultrasound-guided fine-needle aspiration using 22G and 19G aspiration needles for solid pancreatic or peripancreatic masses. Am J Gastroenterol. 2010 Aug;105(8):1739-45. doi: 10.1038/ajg.2010.108. Epub 2010 Mar 9.</citation>
    <PMID>20216532</PMID>
  </reference>
  <reference>
    <citation>Standards of Practice Committee of the American Society for Gastrointestinal Endoscopy, Lichtenstein DR, Jagannath S, Baron TH, Anderson MA, Banerjee S, Dominitz JA, Fanelli RD, Gan SI, Harrison ME, Ikenberry SO, Shen B, Stewart L, Khan K, Vargo JJ. Sedation and anesthesia in GI endoscopy. Gastrointest Endosc. 2008 Nov;68(5):815-26. doi: 10.1016/j.gie.2008.09.029.</citation>
    <PMID>18984096</PMID>
  </reference>
  <reference>
    <citation>Adler DG, Jacobson BC, Davila RE, Hirota WK, Leighton JA, Qureshi WA, Rajan E, Zuckerman MJ, Fanelli RD, Baron TH, Faigel DO; ASGE. ASGE guideline: complications of EUS. Gastrointest Endosc. 2005 Jan;61(1):8-12. Erratum in: Gastrointest Endosc. 2005 Mar;61(3):502.</citation>
    <PMID>15672049</PMID>
  </reference>
  <reference>
    <citation>Al-Haddad M, Wallace MB, Woodward TA, Gross SA, Hodgens CM, Toton RD, Raimondo M. The safety of fine-needle aspiration guided by endoscopic ultrasound: a prospective study. Endoscopy. 2008 Mar;40(3):204-8. Epub 2007 Dec 4.</citation>
    <PMID>18058615</PMID>
  </reference>
  <reference>
    <citation>Carrara S, Arcidiacono PG, Mezzi G, Petrone MC, Boemo C, Testoni PA. Pancreatic endoscopic ultrasound-guided fine needle aspiration: complication rate and clinical course in a single centre. Dig Liver Dis. 2010 Jul;42(7):520-3. doi: 10.1016/j.dld.2009.10.002. Epub 2009 Dec 1.</citation>
    <PMID>19955025</PMID>
  </reference>
  <reference>
    <citation>BoustiÃ¨re C, Veitch A, Vanbiervliet G, Bulois P, Deprez P, Laquiere A, Laugier R, Lesur G, Mosler P, Nalet B, Napoleon B, Rembacken B, Ajzenberg N, Collet JP, Baron T, Dumonceau JM; European Society of Gastrointestinal Endoscopy. Endoscopy and antiplatelet agents. European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy. 2011 May;43(5):445-61. doi: 10.1055/s-0030-1256317. Epub 2011 May 4.</citation>
    <PMID>21547880</PMID>
  </reference>
  <reference>
    <citation>Fayers PM, Machin D. Sample size: how many patients are necessary? Br J Cancer. 1995 Jul;72(1):1-9. Review.</citation>
    <PMID>7599035</PMID>
  </reference>
  <verification_date>November 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 26, 2014</study_first_submitted>
  <study_first_submitted_qc>March 3, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 5, 2014</study_first_posted>
  <last_update_submitted>April 19, 2017</last_update_submitted>
  <last_update_submitted_qc>April 19, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 20, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>French Society of Digestive Endoscopy</investigator_affiliation>
    <investigator_full_name>Christian BOUSTIERE</investigator_full_name>
    <investigator_title>MD, Head of Endoscopy Department, HÃ´pital Saint Joseph, Marseille</investigator_title>
  </responsible_party>
  <keyword>fine needle aspiration under ultrasound endoscopy</keyword>
  <keyword>solid pancreatic tumors</keyword>
  <keyword>head of pancreas</keyword>
  <keyword>19G Flex needle</keyword>
  <keyword>22G standard needle</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Adenocarcinoma</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pancrelipase</mesh_term>
    <mesh_term>Pancreatin</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

